BRPI0821915A2 - Cyclic pyridyl-n- (1,3,4) -thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and use as pharmaceuticals - Google Patents

Cyclic pyridyl-n- (1,3,4) -thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and use as pharmaceuticals

Info

Publication number: BRPI0821915A2
Authority: BR; Brazil
Prior art keywords: thiadiazol; pharmaceuticals; processes; preparation; benzene sulfonamides
Prior art date: 2007-12-26

Application number

BRPI0821915-0A

Other languages

Portuguese (pt)

Inventor

Karl Schoenafinger

Stefanie Keil

Matthias Urmann

Hans Matter

Maike Glien

Wolfgang Wendler

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-26

Filing date

2008-12-12

Publication date

2015-06-16

2008-12-12 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2015-06-16 Publication of BRPI0821915A2 publication Critical patent/BRPI0821915A2/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Reproductive Health (AREA)

BRPI0821915-0A 2007-12-26 2008-12-12 Cyclic pyridyl-n- (1,3,4) -thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and use as pharmaceuticals BRPI0821915A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07291626		2007-12-26
PCT/EP2008/010559 WO2009080223A1 (en)	2007-12-26	2008-12-12	Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals

Publications (1)

Publication Number	Publication Date
BRPI0821915A2 true BRPI0821915A2 (en)	2015-06-16

Family

ID=39356534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821915-0A BRPI0821915A2 (en)	2007-12-26	2008-12-12	Cyclic pyridyl-n- (1,3,4) -thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and use as pharmaceuticals

Country Status (14)

Country	Link
US (1)	US8344004B2 (en)
EP (1)	EP2240474B1 (en)
JP (1)	JP2011507914A (en)
KR (1)	KR20100101165A (en)
CN (1)	CN101910162A (en)
AR (1)	AR072041A1 (en)
AT (1)	ATE549332T1 (en)
AU (1)	AU2008340756A1 (en)
BR (1)	BRPI0821915A2 (en)
CA (1)	CA2710441A1 (en)
IL (1)	IL206531A0 (en)
MX (1)	MX2010006647A (en)
TW (1)	TW200940536A (en)
WO (1)	WO2009080223A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007310897A1 (en) *	2006-10-25	2008-05-02	Neurosearch A/S	Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
WO2011107494A1 (en)	2010-03-03	2011-09-09	Sanofi	Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
CA2798330A1 (en)	2010-05-05	2011-11-10	Infinity Pharmaceuticals, Inc.	Tetrazolones as inhibitors of fatty acid synthase
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
TWI754702B (en) *	2016-12-28	2022-02-11	德商Ｕｃｂ製藥有限公司	(aza)indole- and benzofuran-3-sulfonamides
US20200206309A1 (en) *	2017-07-27	2020-07-02	The Mclean Hospital Corporation	METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
AU2020296361A1 (en)	2019-06-18	2022-01-06	Ctxt Pty Ltd	Benzisoxazole sulfonamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3522638A1 (en) *	1985-06-25	1987-01-08	Diamalt Ag	NEW SOMATOSTATIN DERIVATIVES
WO1997040017A2 (en)	1996-04-19	1997-10-30	Novo Nordisk A/S	Modulators of molecules with phosphotyrosine recognition units
MXPA06000118A (en)	2003-07-08	2006-04-27	Novartis Ag	Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds.
CN101282952A (en)	2005-10-06	2008-10-08	塞诺菲-安万特股份有限公司	Cyclic N- [1,3,4] -thiadiazol-2-yl-benzene sulfonamides, process for their preparation and their use as pharmaceuticals
CN101277940A (en)	2005-10-06	2008-10-01	塞诺菲-安万特股份有限公司	4-Oxy-N-[1,3,4]-thiadiazol-2-yl-benzenesulfonamides, their preparation and their use as medicaments

2008
- 2008-12-12 AU AU2008340756A patent/AU2008340756A1/en not_active Abandoned
- 2008-12-12 CN CN2008801232634A patent/CN101910162A/en active Pending
- 2008-12-12 EP EP08864630A patent/EP2240474B1/en not_active Not-in-force
- 2008-12-12 BR BRPI0821915-0A patent/BRPI0821915A2/en not_active IP Right Cessation
- 2008-12-12 AT AT08864630T patent/ATE549332T1/en active
- 2008-12-12 MX MX2010006647A patent/MX2010006647A/en not_active Application Discontinuation
- 2008-12-12 CA CA2710441A patent/CA2710441A1/en not_active Abandoned
- 2008-12-12 WO PCT/EP2008/010559 patent/WO2009080223A1/en not_active Ceased
- 2008-12-12 JP JP2010540045A patent/JP2011507914A/en not_active Withdrawn
- 2008-12-12 KR KR1020107016753A patent/KR20100101165A/en not_active Withdrawn
- 2008-12-23 AR ARP080105715A patent/AR072041A1/en unknown
- 2008-12-24 TW TW097150346A patent/TW200940536A/en unknown
2010
- 2010-06-09 US US12/796,886 patent/US8344004B2/en not_active Expired - Fee Related
- 2010-06-21 IL IL206531A patent/IL206531A0/en unknown

Also Published As

Publication number	Publication date
US20110224263A1 (en)	2011-09-15
EP2240474A1 (en)	2010-10-20
EP2240474B1 (en)	2012-03-14
AU2008340756A1 (en)	2009-07-02
WO2009080223A1 (en)	2009-07-02
JP2011507914A (en)	2011-03-10
MX2010006647A (en)	2010-08-17
ATE549332T1 (en)	2012-03-15
CA2710441A1 (en)	2009-07-02
CN101910162A (en)	2010-12-08
AR072041A1 (en)	2010-08-04
US8344004B2 (en)	2013-01-01
TW200940536A (en)	2009-10-01
KR20100101165A (en)	2010-09-16
IL206531A0 (en)	2010-12-30

Publication	Publication Date	Title
BRPI0821915A2 (en)	2015-06-16	Cyclic pyridyl-n- (1,3,4) -thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and use as pharmaceuticals
BRPI0914978A2 (en)	2015-10-27	Oxadiazolone-core-group-reinforced n-heterocyclic sulfonamides, processes for their preparation and use as pharmaceuticals
BRPI1010621A2 (en)	2016-06-21	imidazoquinolinones derivative, their pharmaceutical composition and their use
BRPI0821276A2 (en)	2015-06-16	Product and product use
BRPI0918502A2 (en)	2015-12-01	substituted aminoindans and analogs thereof, and their pharmaceutical use
BRPI1009481A2 (en)	2016-03-01	substituted 2-acetamido-5-aryl-1,2,4-triazolones compounds, their preparation process, their use and medicament comprising the same
BR112013016772A2 (en)	2016-10-11	compound, compound use, pharmaceutical composition, oligonucleotide and conjugate
BRPI0912356A2 (en)	2015-10-06	sirtuin modulating compounds, pharmaceutical composition comprising them and their use
BRPI0808098A2 (en)	2014-06-17	4-ARYL-1,4-DI-HYDRO-1,6-NAPHTHRIDINAMIDS REPLACED AND THEIR USE
BRPI1008740A2 (en)	2015-09-01	Pesticide proteins and methods for their use.
BR112012004335A2 (en)	2015-09-08	compound, pharmaceutical composition, and use of the compound.
BRPI0919810A2 (en)	2017-10-31	nitrogen-containing heterocyclic compounds, their preparation and their use as antibacterial medicines
BR112013023174A2 (en)	2016-08-09	"c4-monomethyl triterpenoid-derived compounds, pharmaceutical composition comprising said compounds and use thereof"
BRPI1014583A2 (en)	2016-04-26	heterocyclic sulfonamides, pharmaceutical compositions and uses thereof.
BRPI1011043A2 (en)	2016-09-13	phenylurea compounds and substituted phenylamides as vanyloid receptor ligands, their pharmaceutical composition, their use and their preparation process.
BRPI0818459A2 (en)	2015-04-14	Pharmaceutical composition suitable for ophthalmic use.
BRPI0813680A2 (en)	2015-01-06	IRNA AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME, AS WELL AS USE.
BRPI0806589A2 (en)	2014-05-13	CATALYST, ITS PREPARATION AND USE.
BRPI0813455A2 (en)	2014-12-23	17BETA-CYAN-18A-HOMO-19-NOR-ANDROST-4-ENO DERIVATIVE, ITS USE AND MEDICINAL PRODUCTS CONTAINING THIS DERIVATIVE.
BRPI0808798A2 (en)	2014-10-07	3,5-DISSUBSTITUTED PHENOXYPHENYLAMIDINS AND THEIR USE AS FUNGICIDES
BRPI0807078A2 (en)	2014-04-08	COMPOUND AND PHARMACEUTICAL FORMULATION
BRPI0915552A2 (en)	2017-06-20	cyclosporine derivatives, their use and pharmaceutical composition
BRPI0810654A2 (en)	2014-11-04	Thiadiazolyloxyphenylamidines and their use as fungicides.
BRPI0919807A2 (en)	2015-12-22	heterocyclic nitrogenous compounds, their preparation and their use as antibacterial medicines
BR112013003530A2 (en)	2016-06-28	'' pharmaceutical, kit, use and preparations ''

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.